We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Heart Metabolics Initiates Phase IIb Perhexiline Study
Heart Metabolics Initiates Phase IIb Perhexiline Study
Heart Metabolics launched an open-label Phase IIb study of perhexiline in patients with hypertrophic cardiomyopathy and moderate-to-severe heart failure with preserved left ventricular function.